TCDAQ — Tricida Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Tricida Inc expected to post a loss of $1.03 a share - Earnings Preview
Brief: Tricida Inc Says On March 30, 2021, Tricida And Patheon Entered Into Amendment No. 1 To Agreement
Brief: Tricida Says Co & Patheon Austria GmbH & Co KG Entered Into Binding Term Sheet To Amend Some Terms Of Manufacturing & Commercial Supply Agreement
Brief: Tricida Provides Update On FDA Interactions
Brief: Tricida Reports Q4 And Full Year 2020 Financial Results
Brief: Tricida Inc Files For Mixed Shelf Of Upto $250 Million
Brief: Tricida Inc Entered Into Sixth Amendment To Loan And Security Agreement On Jan 6
U.S. STOCKS ON THE MOVE-Cybersecurity stocks, Boeing, Disney, Zoom
U.S. STOCKS ON THE MOVE-Cybersecurity stocks, Pluristem, Sorrento, GameStop
Tricida drops after revising kidney disease drug trial protocol
Brief: Tricida Announces Updates On Veverimer Development Program
U.S. RESEARCH ROUNDUP-F5 Networks, Taubman Centers, Urovant Sciences
Brief: Morgan Stanley Reports 5.7% Passive Stake In Tricida Inc
Brief: Tricida Q3 Loss Per Share $1.55
U.S. STOCKS ON THE MOVE-Tricida, Cancer Genetics, Penumbra Inc
U.S. STOCKS ON THE MOVE-Cancer Genetics, Tricida, Pinterest
U.S. STOCKS ON THE MOVE-Tricida, Pinterest, Blue Apron Holdings
U.S. STOCKS ON THE MOVE-Pinterest, ChemoCentryx Inc, Kraft Heinz Co
Tricida: Plunges as FDA seeks additional data on kidney disease drug